Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 11.27M P/E - EPS this Y 31.80% Ern Qtrly Grth -
Income -8.77M Forward P/E -1.36 EPS next Y 44.40% 50D Avg Chg -11.00%
Sales 39.14k PEG - EPS past 5Y - 200D Avg Chg -51.00%
Dividend N/A Price/Book 3.17 EPS next 5Y - 52W High Chg -89.00%
Recommedations 2.00 Quick Ratio 3.50 Shares Outstanding 24.08M 52W Low Chg 42.00%
Insider Own 16.30% ROA -97.95% Shares Float 19.95M Beta 4.81
Inst Own 7.57% ROE -293.27% Shares Shorted/Prior 233.34K/310.47K Price 1.13
Gross Margin 100.00% Profit Margin - Avg. Volume 192,922 Target Price 2.00
Oper. Margin -16,295.55% Earnings Date Aug 12 Volume 219,763 Change -4.24%
About Cardio Diagnostics Holdings Inc

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Cardio Diagnostics Holdings Inc News
11/16/24 Cardio Diagnostics Holdings Third Quarter 2024 Earnings: Misses Expectations
11/12/24 Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference
10/01/24 Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
09/17/24 Potential Catalyst Right Around The Corner? CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics' Heart Disease Tests
07/29/24 Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions
06/27/24 Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois
06/25/24 Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum
06/10/24 Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality
07:31 AM Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests
05/13/24 Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week
04/29/24 Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually
04/09/24 Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan
04/04/24 Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre
04/03/24 Cardio Diagnostics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
03/14/24 Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session
03/05/24 Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease
02/15/24 Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout
02/07/24 Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters
02/05/24 Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests
01/24/24 Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor
CDIO Chatroom

User Image 12Dakotadan Posted - 4 minutes ago

$CDIO 👉👉

User Image iambaron Posted - 1 hour ago

$CDIO soon we will have our run like $AGFY

User Image iambaron Posted - 3 hours ago

$CDIO might get my 50k today… not as much as many of you, but $2 and I’m back in it. Deciding between adding here or swinging elsewhere. This could move any day

User Image Alessandro437 Posted - 4 hours ago

$CDIO bought some more today still holding 💎☢️

User Image invbond Posted - 4 hours ago

$CDIO We have some .0001 tic flippers here. They will be dusted.

User Image iambaron Posted - 4 hours ago

$CDIO nice little 360k share spike 25 mins ago. Someone gobbled up some shares. Someone gobbled them up

User Image invbond Posted - 5 hours ago

$CDIO Well said - Will have some big PR’s lined up .

User Image longjohntrader Posted - 5 hours ago

$CDIO Need news for Quantum adoption to lift of.

User Image invbond Posted - 6 hours ago

$CDIO https://x.com/PrecisionHeart/status/1859627841052172559

User Image 10BillyBiggs Posted - 6 hours ago

$CDIO What happened here sheesh? This was looking very promising earlier in the year!?? Dilution incoming or?

User Image Ericmao Posted - 6 hours ago

$CDIO i am waiting for the RS announcement. Then buy ! Cheers !!!

User Image BlindLemonBoosh Posted - 6 hours ago

$CDIO when are you going to stop selling shares?

User Image iambaron Posted - 6 hours ago

$CDIO they haven’t really PR’ed anything in a while. When PRs are scarce I would assume they are planning them for a string of releases.

User Image entrypt Posted - 6 hours ago

$CDIO So much for "PAYMENT NEWS"//Yes you say it will happen! the "PUMP" brought CDIO to about .50 now .23// Forget the news until maybe JAN.//25! Maybe!

User Image Freeyoungthugfr Posted - 7 hours ago

$CDIO guys it’s kinda boring here so I’m chilling and holding but I have a question about another stock if anyone wants to chime in, GVH (Globavend Holdings) filed a 13G Nov. 20th and a company called Globavend Investments now owns 76% of all shares. I have no clue why but it’s my understanding when a company owns this many of their own shares it’s typically super positive. And one more, IBG is a beverage distributor that has deals with Sysco, Coke, and Blue Ridge spirits out of Atlanta they recently IPOd a few months ago worth looking into. Anyways, have a great day everyone.

User Image StockMasterHere Posted - 8 hours ago

$CDT is set to sail beyond $5, and $CDIO will be just as huge as CDT. I am loaded up on CDIO as well. Both for $3-$5

User Image M1LL5 Posted - 9 hours ago

$CDIO awesome gain at CDT. Will bring proceeds here tomorrow averaging out 👍🏻

User Image CantMakeItUp Posted - 9 hours ago

$CDIO well this wants to see .19 before running I see

User Image invbond Posted - 9 hours ago

$CDIO Cardio Diagnostics: A Company with Multiple Catalysts Beyond CMS Pricing- So, don't just focus on CMS instead look beyond. CDIO is strategically positioned for long-term growth with a diverse portfolio of achievements and initiatives. While CMS final pricing is a significant milestone, the company has multiple "irons in the fire" as highlighted below: 👉Revenue and Partnerships 1. Vizient Contract: Secured the Innovative Technology Contract, granting access to 60% of U.S. hospitals and 97% of academic medical centers. 2. Expanded into the employer vertical, with successful partnerships and on-site health fairs. 3. Partnered with Family Medicine Specialists to test their products with major insurance providers like BlueCross BlueShield. 4. Announced an expansion with Family Medicine Specialists for broader adoption in 2024. 5. Entered into a strategic India-focused agreement with Aimil Ltd., targeting a massive untapped market of 1.4 billion people. 👉Reimbursement and FDA Progress 1. Awarded CPT PLA Codes by the American Medical Association for Epi+Gen CHD™ and PrecisionCHD™ tests. 2. Completed FDA pre-submission for PrecisionCHD™, receiving feedback that advances regulatory progress. 👉Products and Evidence 1. Launched PrecisionCHD™, the first fully integrated epigenetic blood test for coronary heart disease detection. 2. Introduced the Actionable Clinical Intelligence Platform, providing vital genetic insights to clinicians. 3. Rolled out CardioInnovate360™, facilitating advanced discovery and validation of cardiovascular biomarkers. 4. Unveiled HeartRisk™, a SaaS-based cardiovascular platform tailored for payers, brokers, and government entities. 5. PrecisionCHD™ clinical evidence was peer-reviewed and published in prestigious medical journals like the Journal of the American Heart Association. 👉Intellectual Property and Operations 1. Patents granted across India, China, Australia, and the U.S., strengthening the company’s IP portfolio. 2. Opened a state-of-the-art operations hub to reduce costs and boost scalability. 3. Added Dr. Damon Broyles and Dr. Vimal Ramjee to its advisory board, enhancing scientific and operational expertise. Remember, CDIO's growth is not reliant on a single catalyst. With advancements in regulatory processes, global market expansions, innovative product launches, and strategic partnerships, the company is set to redefine cardiovascular care. Every milestone achieved underscores its potential for delivering value to patients and shareholders alike. We are holding a gem with tremendous upside potential, as these catalysts could converge to create explosive growth at any moment.

User Image invbond Posted - 10 hours ago

$CDIO Don’t just focus on CMS - This is much bigger than CMS .

User Image Garlic1969 Posted - 11 hours ago

And my heart belongs to $CDIO

User Image Restart23 Posted - 11 hours ago

$CDIO it is common for CMS to announce the finalised reimbursement decision before the effective date to facilitate the necessary preparations of all parties. Stay the course!

User Image Mandi63 Posted - 11 hours ago

$CDIO

User Image Restart23 Posted - 11 hours ago

$CDIO the effective date is January 1 2025. I think CMS will announce the finalised decision before that.

User Image kilo1212 Posted - 21 hours ago

$CDIO But pr comming tomorrow.

User Image kilo1212 Posted - 21 hours ago

$CDIO easy for shorts to have a budddy buy up the ask. then short down and split the profit.

User Image jkatcole Posted - 21 hours ago

$CDIO In terms of the FDA talk, this could be somewhat helpful for CDIO. A new voice may bring the possibility of keeping standards and procedures as they were (without need of Congress) and make the way for our products to obtain its pricing and generate market revenue sooner…

User Image invbond Posted - 22 hours ago

$CDIO Tomorrow, catch our CEO and Co-Founder, Meesha Dogan, Ph.D., on the Strategic Innovation panel discussing the future of AI in value-based care.

User Image Duuri Posted - 23 hours ago

$CDIO goal for tomorrow: stay above .25

User Image BlindLemonBoosh Posted - 1 day ago

$CDIO watch out BlackRock. I'm catching up.

Analyst Ratings
Benchmark Speculative Buy Aug 27, 24
Benchmark Speculative Buy Jun 6, 24
Benchmark Speculative Buy Apr 19, 24
Benchmark Speculative Buy Jun 15, 23
Northland Capital Markets Outperform May 22, 23
Benchmark Speculative Buy Apr 18, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Lau Stanley K. Director Director Jan 31 Option 2.18 917 1,999 91,522 02/05/24
Levy Oded Director Director Dec 31 Option 2.49 5,020 12,500 62,793 01/02/24
Sim Brandon Director Director Dec 31 Option 2.49 5,020 12,500 62,793 01/02/24
Intrater James Director Director Dec 31 Option 2.49 5,020 12,500 62,793 01/02/24
Lau Stanley K. Director Director Dec 31 Option 2.49 6,626 16,499 90,605 01/02/24
Levy Oded Director Director Sep 30 Option 0.34 36,765 12,500 57,773 10/04/23
Intrater James Director Director Sep 30 Option 0.34 36,765 12,500 57,773 10/04/23
Sim Brandon Director Director Sep 30 Option 0.34 36,765 12,500 57,773 10/04/23
Dogan Meeshanthini Chief Executive Offi.. Chief Executive Officer Aug 25 Buy 0.55 18,251 10,038 128,345 09/08/23
Dogan Timur Chief Technology Off.. Chief Technology Officer Aug 25 Buy 0.55 18,251 10,038 128,345 09/08/23
Sim Brandon Director Director Jun 30 Option 1.19 21,008 25,000 21,008 07/05/23
Levy Oded Director Director Jun 30 Option 1.19 21,008 25,000 21,008 07/05/23